135 related articles for article (PubMed ID: 20820649)
1. Concise syntheses of selective inhibitors against α-1,3-galactosyltransferase.
Zhang GL; Zhang LH; Ye XS
Org Biomol Chem; 2010 Nov; 8(22):5062-8. PubMed ID: 20820649
[TBL] [Abstract][Full Text] [Related]
2. A nonionic inhibitor with high specificity for the UDP-Gal donor binding site of human blood group B galactosyltransferase: design, synthesis, and characterization.
Schaefer K; Sindhuwinata N; Hackl T; Kötzler MP; Niemeyer FC; Palcic MM; Peters T; Meyer B
J Med Chem; 2013 Mar; 56(5):2150-4. PubMed ID: 23406460
[TBL] [Abstract][Full Text] [Related]
3. Roles of individual enzyme-substrate interactions by alpha-1,3-galactosyltransferase in catalysis and specificity.
Zhang Y; Swaminathan GJ; Deshpande A; Boix E; Natesh R; Xie Z; Acharya KR; Brew K
Biochemistry; 2003 Nov; 42(46):13512-21. PubMed ID: 14621997
[TBL] [Abstract][Full Text] [Related]
4. Identification of a UDP-Gal: GlcNAc-R galactosyltransferase activity in Escherichia coli VW187.
Montoya-Peleaz PJ; Riley JG; Szarek WA; Valvano MA; Schutzbach JS; Brockhausen I
Bioorg Med Chem Lett; 2005 Feb; 15(4):1205-11. PubMed ID: 15686943
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of UDP-galactose binding by alpha-1,3-galactosyltransferase (alpha3GT): role of negative charge on aspartic acid 316 in structure and activity.
Tumbale P; Jamaluddin H; Thiyagarajan N; Brew K; Acharya KR
Biochemistry; 2008 Aug; 47(33):8711-8. PubMed ID: 18651752
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of an alpha-galactosyltransferase from Trypanosoma brucei by synthetic substrate analogues.
Kolb V; Amann F; Schmidt RR; Duszenko M
Glycoconj J; 1999 Sep; 16(9):537-44. PubMed ID: 10815990
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 2-deoxy-hexopyranosyl derivatives of uridine as donor substrate analogues for glycosyltransferases.
Wandzik I; Bieg T; Czaplicka M
Bioorg Chem; 2009 Dec; 37(6):211-6. PubMed ID: 19765794
[TBL] [Abstract][Full Text] [Related]
8. Novel aspects of interaction between UDP-gal and GlcNAc beta-1,4-galactosyltransferase: transferability and remarkable inhibitory activity of UDP-(mono-O-methylated gal), UDP-Fuc and UDP-man.
Endo T; Kajihara Y; Kodama H; Hashimoto H
Bioorg Med Chem; 1996 Nov; 4(11):1939-48. PubMed ID: 9007278
[TBL] [Abstract][Full Text] [Related]
9. The first C-glycosidic analogue of a novel galactosyltransferase inhibitor.
Descroix K; Wagner GK
Org Biomol Chem; 2011 Mar; 9(6):1855-63. PubMed ID: 21267505
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of beta-1,4- and alpha-1,3-galactosyltransferases: donor sugar-nucleotide based approach.
Takayama S; Chung SJ; Igarashi Y; Ichikawa Y; Sepp A; Lechler RI; Wu J; Hayashi T; Siuzdak G; Wong CH
Bioorg Med Chem; 1999 Feb; 7(2):401-9. PubMed ID: 10218835
[TBL] [Abstract][Full Text] [Related]
11. Structure of bovine alpha-1,3-galactosyltransferase and its complexes with UDP and DPGal inferred from molecular modeling.
Rao M; Tvaroska I
Proteins; 2001 Sep; 44(4):428-34. PubMed ID: 11484220
[TBL] [Abstract][Full Text] [Related]
12. Diastereoselective synthesis of novel iminosugar-containing UDP-Galf mimics: potential inhibitors of UDP-Gal mutase and UDP-Galf transferases.
Liautard V; Christina AE; Desvergnes V; Martin OR
J Org Chem; 2006 Sep; 71(19):7337-45. PubMed ID: 16958528
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of fluorescently labelled and internally quenched UDP-Gal probes.
Schweizer F
Carbohydr Res; 2007 Sep; 342(12-13):1831-40. PubMed ID: 17475229
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies on the uridine-5'-diphosphate-galactose: glycoprotein galactosyltransferase activity in rat liver and Zajdela ascitic hepatoma.
Ivanov D; Karaivanova V; Ivanov S; Chelibonova-Lorer H
Cancer Biochem Biophys; 1994 Apr; 14(1):35-40. PubMed ID: 7540947
[TBL] [Abstract][Full Text] [Related]
15. [Existence of UDP galactose: galactosyltransferase activity at the external surface of cultured neurons].
Matsui Y; Lombard D; Hoflack B; Harth S; Massarelli R; Mandel P; Dreyfus H
C R Seances Acad Sci III; 1983; 296(12):563-7. PubMed ID: 6409364
[TBL] [Abstract][Full Text] [Related]
16. Fragment-based screening of the donor substrate specificity of human blood group B galactosyltransferase using saturation transfer difference NMR.
Blume A; Angulo J; Biet T; Peters H; Benie AJ; Palcic M; Peters T
J Biol Chem; 2006 Oct; 281(43):32728-40. PubMed ID: 16923820
[TBL] [Abstract][Full Text] [Related]
17. Binding of an acceptor substrate analog enhances the enzymatic activity of human blood group B galactosyltransferase.
Sindhuwinata N; Munoz E; Munoz FJ; Palcic MM; Peters H; Peters T
Glycobiology; 2010 Jun; 20(6):718-23. PubMed ID: 20154292
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of beta1,4-galactosyltransferase complex with UDP-Gal reveals an oligosaccharide acceptor binding site.
Ramakrishnan B; Balaji PV; Qasba PK
J Mol Biol; 2002 Apr; 318(2):491-502. PubMed ID: 12051854
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic characterization of UDP-galactose:FdSdG galactosyltransferase in purified liver plasma membrane.
Fernandez-Briera A; Louisot P; Morelis R
Biochem Int; 1989 Feb; 18(2):415-28. PubMed ID: 2504163
[TBL] [Abstract][Full Text] [Related]
20. Blood group B galactosyltransferase: insights into substrate binding from NMR experiments.
Angulo J; Langpap B; Blume A; Biet T; Meyer B; Krishna NR; Peters H; Palcic MM; Peters T
J Am Chem Soc; 2006 Oct; 128(41):13529-38. PubMed ID: 17031966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
